ASL Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ASL Antibodies for advanced research in molecular biology. Monoclonal ASL Antibodies support various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ASL, or argininosuccinate lyase, plays a critical role in the urea cycle, catalyzing the conversion of argininosuccinate to arginine and fumarate. This process is essential for the detoxification of ammonia in the liver, making ASL vital for maintaining nitrogen balance in the body. Dysregulation of ASL can lead to metabolic disorders, highlighting its significance in both health and disease. Understanding ASL function is crucial for developing therapeutic strategies for urea cycle disorders. Research into ASL expression patterns helps identify potential biomarkers for metabolic conditions. ASL investigation continues to reveal new insights into nitrogen metabolism and cellular homeostasis. Santa Cruz Biotechnology monoclonal ASL Antibodies enable researchers worldwide to advance our understanding of metabolic pathways and disease mechanisms.